UNSPSC 85713336: Removal of autologous tissue substitute from left metacarpocarpal joint, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of autologous tissue substitute from left metacarpocarpal joint, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RPT07Z

UNSPSC 85713336 Removal of autologous tissue substitute from left metacarpocarpal joint, open approach is a Commodity code that shows little relevant recent procurement activity under state and local government solicitations. The code nominally describes a specific orthopedic surgical procedure, but the recent opportunities tagged under it do not reflect procurement of that service. Instead, the opportunities posted between July and September 2026 span independent medical evaluation services, occupational health surveillance, pharmacy benefit management, surgical center-of-excellence networks, temporary health professional staffing, and youth detention medical care — none of which align with removal of tissue substitutes from hand joints. The mismatch suggests either a data-tagging anomaly or that the code is not actively used by state and local procurement offices for the procedure it nominally describes.

The jurisdictions posting opportunities under this code include city retirement systems (Phoenix), county health systems (Santa Clara), county procurement offices (Collier, Harris), state transportation agencies (Washington Department of Transportation), and municipal benefits administrators (Long Beach). Geographic activity spans Arizona, Florida, California, Washington, and Texas, with no single region dominating. No representative opportunities directly procure the surgical service named in the code; the most recent postings are broader health-care contracting vehicles unrelated to the specific procedure. Pursuit of this code for business development purposes is not warranted unless your firm specializes in tissue-substitute surgical implants and has evidence of active state or local procurement demand outside the tagged opportunities shown here.